Singular Health Group Limited (ASX:SHG) is a medical technology company that empowers practitioners and patients via personalised surgical planning and design solutions that drive better health outcomes. Singular Health has developed a proprietary Volumetric Rendering Platform (VRP) that leverages existing 2D radiological images to generate fully-immersive patient-specific 3D/VR models. While the Company’s core focus is on the medical sector, Singular Health’s VRP technology is applicable to other sectors in which the visualisation of dynamic data is crucial, with it utilised in the mining sector. Complementing its VRP technology, Singular Health has developed a Virtual Surgical Planning and Design software and has invested in a 25% stake in medical-grade 3D printing company Additive Engineering. These investments and developments represent key milestones in Singular Health’s efforts to commercialise its ‘Scan to Surgery’ initiative, a world-first vertically integrated platform that revolutionises the planning and execution of personalised surgical procedures. A successful full-scale commercialisation of this end-to-end personalised surgical planning platform will give Singular Health the capability to penetrate a multi-billion-dollar global market opportunity in the medical visualisation and advanced manufacturing spaces. With Singular Health, practitioners are empowered by having the ability to collaborate with manufacturers of patient-specific medical components in real-time, while patients benefit from having access to easily comprehensible and enhanced medical information. To learn more, please visit: www.singular.health
